A new case of acute nonlymphocytic leukemia (French–American–British subtype M1) with double minutes and c-MYC amplification

2002 ◽  
Vol 132 (2) ◽  
pp. 161-164 ◽  
Author(s):  
Natàlia Rodon ◽  
Francesc Solé ◽  
Blanca Espinet ◽  
Marta Salido ◽  
Lourdes Zamora ◽  
...  
Blood ◽  
1986 ◽  
Vol 67 (4) ◽  
pp. 1048-1053 ◽  
Author(s):  
PA Dinndorf ◽  
RG Andrews ◽  
D Benjamin ◽  
D Ridgway ◽  
L Wolff ◽  
...  

Monoclonal antibodies that react with hematopoietic cells and their precursors in a stage and lineage restricted fashion were used in indirect immunofluorescence assays to examine leukemic cells from 105 pediatric age patients. The differentiative states of blasts from 42 patients with acute nonlymphocytic leukemia (ANLL) were defined by these antibodies. When these were compared to their morphologic and histochemical levels of differentiation as defined by the French- American-British (FAB) classification, no direct relationship was found. The reactivity of these antibodies with leukemic cells from 63 patients with acute lymphocytic leukemiA (ALL) was also investigated, and the usefulness of these antibodies in distinguishing leukemias of myeloid from those of lymphoid origin was demonstrated.


Blood ◽  
1985 ◽  
Vol 66 (6) ◽  
pp. 1362-1370 ◽  
Author(s):  
MA Bitter ◽  
ME Neilly ◽  
MM Le Beau ◽  
MG Pearson ◽  
JD Rowley

Abstract Fourteen patients with acute nonlymphocytic leukemia (ANLL) or dysmyelopoietic syndromes were found to have abnormalities involving the long arm of chromosome 3. In eight patients, the structural rearrangements involved both bands 3q21 and 3q26 and included t(3;3) (four patients), inv(3) (three patients), and ins(5;3) (one patient). Before treatment, seven of these eight patients had platelet counts above 100,000 per microliter, five had normal or elevated platelet counts, and four had significantly elevated platelet counts (600,000 to 1,731,000 per microliter). In each of the eight cases, normal or elevated platelet counts were associated with marked abnormalities of megakaryocytopoiesis, including increased numbers of megakaryocytes and numerous micromegakaryocytes. Classification within the French-American- British system was difficult in most of these cases; however, the leukemia in five of the eight patients with abnormalities of chromosome 3 that involved both bands 3q21 and 3q26 was classified as M4. The remaining six of the 14 patients had translocations between chromosome 3 and another chromosome. None involved both bands 3q21 and 3q26, and a break in either q21 or q26 was noted in only two patients. One of the six, who had ANLL (M4) with a normal platelet count, had a 3;5 translocation which involved band 3q25. These data suggest that in patients with ANLL, abnormalities of chromosome 3 which simultaneously involve bands 3q21 and 3q26 are associated with unusually high platelet counts.


Blood ◽  
1986 ◽  
Vol 67 (5) ◽  
pp. 1328-1332 ◽  
Author(s):  
C Mecucci ◽  
A Van Orshoven ◽  
G Tricot ◽  
JL Michaux ◽  
A Delannoy ◽  
...  

Abstract We present four patients with acute nonlymphocytic leukemia, one M2 and three M4 French-American-British (FAB) types and one patient with refractory anemia with excess of blasts in transformation who at diagnosis had trisomy of chromosome 4 as the primary karyotypic anomaly. This chromosome anomaly probably defines a previously undescribed subset of acute nonlymphoid leukemias. Hematologic characteristics commonly found in these patients were dysplastic features of all bone marrow lineages, suggesting that trisomy 4- associated disorders involve the early myeloid hematopoietic stem cell.


Blood ◽  
1986 ◽  
Vol 67 (4) ◽  
pp. 1048-1053 ◽  
Author(s):  
PA Dinndorf ◽  
RG Andrews ◽  
D Benjamin ◽  
D Ridgway ◽  
L Wolff ◽  
...  

Abstract Monoclonal antibodies that react with hematopoietic cells and their precursors in a stage and lineage restricted fashion were used in indirect immunofluorescence assays to examine leukemic cells from 105 pediatric age patients. The differentiative states of blasts from 42 patients with acute nonlymphocytic leukemia (ANLL) were defined by these antibodies. When these were compared to their morphologic and histochemical levels of differentiation as defined by the French- American-British (FAB) classification, no direct relationship was found. The reactivity of these antibodies with leukemic cells from 63 patients with acute lymphocytic leukemiA (ALL) was also investigated, and the usefulness of these antibodies in distinguishing leukemias of myeloid from those of lymphoid origin was demonstrated.


Blood ◽  
1986 ◽  
Vol 67 (5) ◽  
pp. 1328-1332
Author(s):  
C Mecucci ◽  
A Van Orshoven ◽  
G Tricot ◽  
JL Michaux ◽  
A Delannoy ◽  
...  

We present four patients with acute nonlymphocytic leukemia, one M2 and three M4 French-American-British (FAB) types and one patient with refractory anemia with excess of blasts in transformation who at diagnosis had trisomy of chromosome 4 as the primary karyotypic anomaly. This chromosome anomaly probably defines a previously undescribed subset of acute nonlymphoid leukemias. Hematologic characteristics commonly found in these patients were dysplastic features of all bone marrow lineages, suggesting that trisomy 4- associated disorders involve the early myeloid hematopoietic stem cell.


Blood ◽  
1985 ◽  
Vol 66 (6) ◽  
pp. 1362-1370
Author(s):  
MA Bitter ◽  
ME Neilly ◽  
MM Le Beau ◽  
MG Pearson ◽  
JD Rowley

Fourteen patients with acute nonlymphocytic leukemia (ANLL) or dysmyelopoietic syndromes were found to have abnormalities involving the long arm of chromosome 3. In eight patients, the structural rearrangements involved both bands 3q21 and 3q26 and included t(3;3) (four patients), inv(3) (three patients), and ins(5;3) (one patient). Before treatment, seven of these eight patients had platelet counts above 100,000 per microliter, five had normal or elevated platelet counts, and four had significantly elevated platelet counts (600,000 to 1,731,000 per microliter). In each of the eight cases, normal or elevated platelet counts were associated with marked abnormalities of megakaryocytopoiesis, including increased numbers of megakaryocytes and numerous micromegakaryocytes. Classification within the French-American- British system was difficult in most of these cases; however, the leukemia in five of the eight patients with abnormalities of chromosome 3 that involved both bands 3q21 and 3q26 was classified as M4. The remaining six of the 14 patients had translocations between chromosome 3 and another chromosome. None involved both bands 3q21 and 3q26, and a break in either q21 or q26 was noted in only two patients. One of the six, who had ANLL (M4) with a normal platelet count, had a 3;5 translocation which involved band 3q25. These data suggest that in patients with ANLL, abnormalities of chromosome 3 which simultaneously involve bands 3q21 and 3q26 are associated with unusually high platelet counts.


1991 ◽  
Vol 9 (2) ◽  
pp. 247-258 ◽  
Author(s):  
C P Steuber ◽  
C Civin ◽  
J Krischer ◽  
S Culbert ◽  
A Ragab ◽  
...  

Two hundred fifty-six children with previously untreated acute nonlymphocytic leukemia (ANLL) were evaluated on a Pediatric Oncology Group (POG) phase III randomized trial of both induction and continuation chemotherapies. Induction therapy compared vincristine, cytarabine, and dexamethasone (VADx) with daunorubicin, cytarabine, and thioguanine (DAT). The complete remission (CR) rate using DAT was superior (82% v 61%, P = .02). Postremission therapy consisted of either "standard" two-cycle therapy or a more intensive four-cycle regimen given for 2 years. Overall, there was no difference in outcome for patients randomized to either continuation regimen. The overall complete continuous remission rate (CCR) for the "best" induction/continuation therapy combination at 2 years was .50 (SE = .06), at 3 years was .35 (.04), and at 4 years was .34 (.05). Analysis of selected clinical and laboratory parameters demonstrated differences in induction responses favoring DAT induction but did not impact eventual disease-free survival. There were two subgroups of patients who responded better to four-cycle continuation therapy. These were patients with French-American-British (FAB) M1/M2 (2-year CCR was .20 v .44, P = .01) and patients older than 10 years at diagnosis (.32 v .62, P = .004).


2004 ◽  
Vol 32 (01) ◽  
pp. 15-20
Author(s):  
I. Kathmann ◽  
D. Ledieu ◽  
K. Allenspach ◽  
G. Fodor ◽  
A. Jaggy ◽  
...  

Zusammenfassung:Als Leukämie bezeichnet man eine neoplastische Wucherung von hämatopoetischen Vorläuferzellen im Knochenmark. Entsprechend der FAB-(French-American-British-) Klassifizierung beim Menschen können auch Leukämien beim Tier durch die normale Zytologie und Resultate immunhistochemischer und zytoenzymatischer Untersuchungen in weitere Gruppen unterteilt werden. Akute Leukämien kommen beim Hund selten vor. Das Auftreten von Krampfanfällen im Zusammenhang mit einer akuten myeloiden Leukämie beim Hund wurde unseres Wissens noch nie beschrieben. Es wird ein Literaturüberblick gegeben und der Fall einer vierjährigen Dalmatiner-Mischlingshündin beschrieben, die wegen epileptischer Krampfanfälle, Schwächezuständen und Inkoordination überwiesen wurde. Unter Berücksichtigung der zytologischen, zytoenzymatischen und immunhistochemischen Resultate handelte es sich um eine akute myeloblastische Leukämie (AML1 oder AML5).


1980 ◽  
Vol 79 (2) ◽  
pp. 334-339 ◽  
Author(s):  
Amelia Reichmann ◽  
Robert H. Riddell ◽  
Paulette Martin ◽  
Bernard Levin

Blood ◽  
1983 ◽  
Vol 61 (5) ◽  
pp. 867-870 ◽  
Author(s):  
CW Jackson ◽  
GV Dahl

Abstract Small megakaryocytes are frequently seen in patients with acute nonlymphocytic leukemia (ANLL). In this study, median megakaryocyte diameters were determined in marrow biopsy specimens of 32 children at diagnosis of ANLL and related to platelet count and chemotherapeutic response. The association between median megakaryocyte size and time-to- failure was striking. Seven of 9 patients with median megakaryocyte diameters greater than 20 microns remain in continuous complete remission for more than 3 yr, whereas 20 of 23 patients with smaller median megakaryocyte diameters failed therapy within 15 mo (p = 0.002). By Cox-regression analysis, megakaryocyte size had independent prognostic value (p less than 0.001), surpassing that of spleen size, the only other feature having significant association with time-to- failure. Megakaryocyte size at diagnosis may be useful for predicting the likelihood of prolonged complete remission in ANLL.


Sign in / Sign up

Export Citation Format

Share Document